Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Powell Industries (POWL) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

Powell IndustriesTrade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

Powell Industries vs State Street SPDR S&P Biotech ETF — how do they compare? Powell Industries trades at $180.26 (market cap $6.65B), while State Street SPDR S&P Biotech ETF trades at $159.93. The key difference: Powell Industries pays a 0.2% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Powell Industries nearer its low. Which is the better fit depends on your goals.

POWLXBI
Market Cap
$6.65B
Sector
IndustrialsBroad Market / Factor
52-Week High
$322.05$169.55
52-Week Low
$92.33$93.43
Enterprise Value
$6.02B
Dividend Yield
0.2%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Powell Industries

No Aura AI signal available yet.

State Street SPDR S&P Biotech ETF

XBI trades at $161.97, down 1.12% today, with technical indicators showing mixed signals amid a bearish overall trend. The ETF holds over 150 biotech companies and has rallied 76% in the past year, driven by M&A activity and positive clinical trial catalysts. Analyst coverage remains limited with a single hold rating, while recent news highlights sector optimism around cancer vaccine breakthroughs and improved capital access.

Outlook remains cautiously optimistic with potential for 8-14% returns over 6-12 months, though high volatility and regulatory risks persist. Key opportunities include ongoing pharmaceutical M&A and innovation in immunotherapy, while risks center on sector-specific volatility and policy uncertainty.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Powell Industries

Powell Industries designs and manufactures electrical equipment and engineered solutions for power distribution and control. Its products are used across energy, utility, industrial, and commercial infrastructure.

Read more on POWL

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI